ARS-interacting multi-functional protein 1 induces proliferation of human bone marrow-derived mesenchymal stem cells by accumulation of β-catenin via fibroblast growth factor receptor 2-mediated activation of Akt

Stem Cells and Development

Volumn 22, Issue 19, 2013, Pages 2630-2640

  Kim, Seo Yoon ^a   Son, Woo Sung ^a   Park, Min Chul ^b   Kim, Chul Min ^a   Cha, Byung Hyun ^a   Yoon, Kang Jun ^c   Lee, Soo Hong ^a   Park, Sang Gyu ^a,d  

^a CHA University   (South Korea)

^b Seoul National University   (South Korea)

^c Kangnam St Mary's Hospital   (South Korea)

^d CHA Stem Cell Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ARS INTERACTING MULTIFUNCTIONAL PROTEIN 1; BETA CATENIN; CYCLIN D1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GLYCOGEN SYNTHASE KINASE 3BETA; MYC PROTEIN; PEPTIDES AND PROTEINS; PROTEIN KINASE B; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME INHIBITION; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY;

ACTIVE TRANSPORT, CELL NUCLEUS; ADIPOCYTES; ANIMALS; BETA CATENIN; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; CHROMONES; CYCLIN D1; CYTOKINES; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MORPHOLINES; NEOPLASM PROTEINS; OSTEOCYTES; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RNA-BINDING PROTEINS; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84884553236     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0714     Document Type: Article

References (51)

1. Cho KJ, KA Trzaska, SJ Greco, J McArdle, FS Wang, JH Ye and P Rameshwar. (2005). Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells 23:383-391.
2. Rose RA, H Jiang, X Wang, S Helke, JN Tsoporis, N Gong, SC Keating, TG Parker, PH Backx and A Keating. (2008). Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Stem Cells 26:2884-2892.
3. Schulze M, F Belema-Bedada, A Technau and T Braun. (2005). Mesenchymal stem cells are recruited to striated muscle by NFAT/IL-4-mediated cell fusion. Genes Dev 19:1787-1798.
4. Snykers S, J De Kock, V Rogiers and T Vanhaecke. (2009). In vitro differentiation of embryonic and adult stem cells into hepatocytes: State of the art. Stem Cells 27:577-605.
5. Oswald J, S Boxberger, B Jorgensen, S Feldmann, G Ehninger, M Bornhauser and C Werner. (2004). Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22:377-384.
6. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
7. Pereira RF, KW Halford, MD O'Hara, DB Leeper, BP Sokolov, MD Pollard, O Bagasra and DJ Prockop. (1995). Cultured adherent cells from marrow can serve as longlasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 92:4857-4861.
8. Friedenstein AJ, JF Gorskaja and NN Kulagina. (1976). Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267-274.
9. Wagner W, F Wein, A Seckinger, M Frankhauser, U Wirkner, U Krause, J Blake, C Schwager, V Eckstein, W Ansorge and AD Ho. (2005). Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33:1402-1416.
10. Katz AJ, A Tholpady, SS Tholpady, H Shang and RC Ogle. (2005). Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 23:412-423.
11. Kern S, H Eichler, J Stoeve, H Kluter and K Bieback. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301.
12. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
13. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
14. Tamama K, VH Fan, LG Griffith, HC Blair and A Wells. (2006). Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 24:686-695.
15. Choi SC, SJ Kim, JH Choi, CY Park, WJ Shim and DS Lim. (2008). Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Stem Cells Dev 17:725-736.
16. Calarco A, O Petillo, M Bosetti, A Torpedine, M Cannas, L Perrone, U Galderisi, MA Melone and G Peluso. (2010). Controlled delivery of the heparan sulfate/FGF-2 complex by a polyelectrolyte scaffold promotes maximal hMSC proliferation and differentiation. J Cell Biochem 110:903-909.
17. He X, C H'Ng S, DT Leong, DW Hutmacher and AJ Melendez. (2010). Sphingosine-1-phosphate mediates proliferation maintaining the multipotency of human adult bone marrow and adipose tissue-derived stem cells. J Mol Cell Biol 2:199-208.
18. Quevillon S, F Agou, JC Robinson and M Mirande. (1997). The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine. J Biol Chem 272:32573-32579.
19. Matschurat S, UE Knies, V Person, L Fink, B Stoelcker, C Ebenebe, HA Behrensdorf, J Schaper and M Clauss. (2003). Regulation of EMAP II by hypoxia. Am J Pathol 162:93-103.
20. Park SG, H Shin, YK Shin, Y Lee, EC Choi, BJ Park and S Kim. (2005). The novel cytokine p43 stimulates dermal fibroblast proliferation and wound repair. Am J Pathol 166:387-398.
21. Kim E, SH Kim, S Kim, D Cho and TS Kim. (2008). AIMP1/p43 protein induces the maturation of bone marrow-derived dendritic cells with T helper type 1-polarizing ability. J Immunol 180:2894-2902.
22. Kim E, SH Kim, S Kim and TS Kim. (2006). The novel cytokine p43 induces IL-12 production in macrophages via NFAIMP1 kappaB activation, leading to enhanced IFN-gamma production in CD4+ T cells. J Immunol 176:256-264.
23. Ko Y-G, H Park, T Kim, J-W Lee, SG Park, W Seol, JE Kim, W-H Lee, S-H Kim, JE Park and S Kim. (2001). A cofactor of tRNA synthetase, p43, is secreted to up-regulate proinflammatory genes. J Biol Chem 276:23028-32303.
24. Park H, SG Park, J-W Lee, T Kim, G Kim, Y-G Ko and S Kim. (2002). Monocyte cell adhesion induced by a human aminoacyl-tRNA synthetase associated factor, p43: Identification of the related adhesion molecules and signal pathways. J Leukoc Biol 71:223-230.
25. Park SG, YS Kang, YH Ahn, SH Lee, KR Kim, KW Kim, GY Koh, YG Ko and S Kim. (2002). Dose-dependent biphasic activity of tRNA synthetase-associating factor, p43, in angiogenesis. J Biol Chem 277:45243-45248.
26. Park SG, YS Kang, JY Kim, CS Lee, YG Ko, WJ Lee, KU Lee, YI Yeom and S Kim. (2006). Hormonal activity of AIMP1/p43 for glucose homeostasis. Proc Natl Acad Sci U S A 103:14913-14918.
27. Han JM, SG Park, Y Lee and S Kim. (2006). Structural separation of different extracellular activities in aminoacyltRNA synthetase-interacting multi-functional protein, p43/AIMP1. Biochem Biophys Res Commun 342:113-118.
28. Leaver-Fay A, M Tyka, SM Lewis, OF Lange, J Thompson, R Jacak, K Kaufman, PD Renfrew, CA Smith, et al. (2011). ROSETTA3: An object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol 487:545-574.
29. Kozakov D, DR Hall, D Beglov, R Brenke, SR Comeau, Y Shen, K Li, J Zheng, P Vakili, I Paschalidis and S Vajda. (2010). Achieving reliability and high accuracy in automated protein docking: ClusPro, PIPER, SDU, and stability analysis in CAPRI rounds 13-19. Proteins 78:3124-3130.
30. Kozakov D, R Brenke, SR Comeau and S Vajda. (2006). PIPER: An FFT-based protein docking program with pairwise potentials. Proteins 65:392-406.
31. Comeau SR, DW Gatchell, S Vajda and CJ Camacho. (2004). ClusPro: A fully automated algorithm for protein-protein docking. Nucleic Acids Res 32:W96-W99.
32. Comeau SR, DW Gatchell, S Vajda and CJ Camacho. (2004). ClusPro: An automated docking and discrimination method for the prediction of protein complexes. Bioinformatics 20:45-50.
33. Benyamini H and A Friedler. (2011). The ASPP interaction network: Electrostatic differentiation between pro- and antiapoptotic proteins. J Mol Recognit 24:266-274.
34. Case DA, TE Cheatham, 3rd., T Darden, H Gohlke, R Luo, KM Merz, Jr., A Onufriev, C Simmerling, B Wang and RJ Woods. (2005). The Amber biomolecular simulation programs. J Comput Chem 26:1668-1688.
35. Pettersen EF, TD Goddard, CC Huang, GS Couch, DM Greenblatt, EC Meng and TE Ferrin. (2004). UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem 25:1605-1612.
36. Andrusier N, R Nussinov and HJ Wolfson. (2007). FireDock: Fast interaction refinement in molecular docking. Proteins 69:139-159.
37. Mashiach E, D Schneidman-Duhovny, N Andrusier, R Nussinov and HJ Wolfson. (2008). FireDock: A web server for fast interaction refinement in molecular docking. Nucleic Acids Res 36:W229-W232.
38. Baker NA, D Sept, S Joseph, MJ Holst and JA McCammon. (2001). Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc Natl Acad Sci U S A 98:10037-10041.
39. Ibrahimi OA, AV Eliseenkova, AN Plotnikov, K Yu, DM Ornitz and M Mohammadi. (2001). Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci U S A 98:7182-7187.
40. Cohen P and S Frame. (2001). The renaissance of GSK3. Nat Rev Mol Cell Biol 2:769-776.
41. Cross DA, DR Alessi, P Cohen, M Andjelkovich and BA Hemmings. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789.
42. Liu C, Y Li, M Semenov, C Han, GH Baeg, Y Tan, Z Zhang, X Lin and X He. (2002). Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108:837-847.
43. Behrens J, JP von Kries, M Kuhl, L Bruhn, D Wedlich, R Grosschedl and W Birchmeier. (1996). Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638-642.
44. Molenaar M, M van de Wetering, M Oosterwegel, J Peterson-Maduro, S Godsave, V Korinek, J Roose, O Destree and H Clevers. (1996). XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86:391-399.
45. Willert K and KA Jones. (2006). Wnt signaling: Is the party in the nucleus?. Genes Dev 20:1394-1404.
46. Park H, SG Park, J Kim, YG Ko and S Kim. (2002). Signaling pathways for TNF production induced by human aminoacyltRNAsynthetase-associating factor, p43. Cytokine 20:148-153.
47. Brooks AN, E Kilgour and PD Smith. (2012). Molecular pathways: Fibroblast growth factor signaling: A new therapeutic opportunity in cancer. Clin Cancer Res 18:1855-1862.
48. Coutu DL and J Galipeau. (2011). Roles of FGF signaling in stem cell self-renewal, senescence and aging. Aging (Albany NY) 3:920-933.
49. Gille H, M Kortenjann, O Thomae, C Moomaw, C Slaughter, MH Cobb and PE Shaw. (1995). ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 14:951-962.
50. Gille H, AD Sharrocks and PE Shaw. (1992). Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358:414-417.
51. Marais R, J Wynne and R Treisman. (1993). The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381-393.